Liskamp RM - Search Results

1

Replacement of the intervening amino acid sequence of a Syk-binding diphosphopeptide by a nonpeptide spacer with preservation of high affinity.

Dekker FJ, de Mol NJ, van Ameijde J, Fischer MJ, Ruijtenbeek R, Redegeld FA, Liskamp RM. Dekker FJ, et al. Among authors: liskamp rm. Chembiochem. 2002 Mar 1;3(2-3):238-42. doi: 10.1002/1439-7633(20020301)3:2/3<238::AID-CBIC238>3.0.CO;2-W. Chembiochem. 2002. PMID: 11921404 No abstract available.

2

Solid-phase synthesis of oligourea peptidomimetics employing the Fmoc protection strategy.

Boeijen A, van Ameijde J, Liskamp RM. Boeijen A, et al. Among authors: liskamp rm. J Org Chem. 2001 Dec 14;66(25):8454-62. doi: 10.1021/jo010656q. J Org Chem. 2001. PMID: 11735525

3

Characterization of a phosphorylated peptide and peptoid and peptoid-peptide hybrids by mass spectrometry.

Ruijtenbeek R, Versluis C, Heck AJ, Redegeld FA, Nijkamp FP, Liskamp RM. Ruijtenbeek R, et al. Among authors: liskamp rm. J Mass Spectrom. 2002 Jan;37(1):47-55. doi: 10.1002/jms.245. J Mass Spectrom. 2002. PMID: 11813310

4

Peptoid - peptide hybrids that bind Syk SH2 domains involved in signal transduction.

Ruijtenbeek R, Kruijtzer JA, van de Wiel W, Fischer MJ, Flück M, Redegeld FA, Liskamp RM, Nijkamp FP. Ruijtenbeek R, et al. Among authors: liskamp rm. Chembiochem. 2001 Mar 2;2(3):171-9. doi: 10.1002/1439-7633(20010302)2:3<171::AID-CBIC171>3.0.CO;2-B. Chembiochem. 2001. PMID: 11828442

5

Role of solution conformation and flexibility of short peptide ligands that bind to the p56(lck) SH2 domain.

Dekker FJ, de Mol NJ, Bultinck P, Kemmink J, Hilbers HW, Liskamp RM. Dekker FJ, et al. Among authors: liskamp rm. Bioorg Med Chem. 2003 Mar 20;11(6):941-9. doi: 10.1016/s0968-0896(02)00536-9. Bioorg Med Chem. 2003. PMID: 12614879

6

Amino propynyl benzoic acid building block in rigid spacers of divalent ligands binding to the Syk SH2 domains with equally high affinity as the natural ligand.

Dekker FJ, de Mol NJ, Fischer MJ, Liskamp RM. Dekker FJ, et al. Among authors: liskamp rm. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1241-4. doi: 10.1016/s0960-894x(03)00117-3. Bioorg Med Chem Lett. 2003. PMID: 12657254

7

Synthesis of novel trivalent amino acid glycoconjugates based on the cyclotriveratrylene ('CTV') scaffold.

van Ameijde J, Liskamp RM. van Ameijde J, et al. Among authors: liskamp rm. Org Biomol Chem. 2003 Aug 7;1(15):2661-9. doi: 10.1039/b303795a. Org Biomol Chem. 2003. PMID: 12948190

8

Cyclic phosphopeptides for interference with Grb2 SH2 domain signal transduction prepared by ring-closing metathesis and phosphorylation.

Dekker FJ, de Mol NJ, Fischer MJ, Kemmink J, Liskamp RM. Dekker FJ, et al. Among authors: liskamp rm. Org Biomol Chem. 2003 Oct 7;1(19):3297-303. doi: 10.1039/b306681a. Org Biomol Chem. 2003. PMID: 14584793

9

Adhesion inhibition of F1C-fimbriated Escherichia coli and Pseudomonas aeruginosa PAK and PAO by multivalent carbohydrate ligands.

Autar R, Khan AS, Schad M, Hacker J, Liskamp RM, Pieters RJ. Autar R, et al. Among authors: liskamp rm. Chembiochem. 2003 Dec 5;4(12):1317-25. doi: 10.1002/cbic.200300719. Chembiochem. 2003. PMID: 14661274

10

Structure-activity studies on the corticotropin releasing factor antagonist astressin, leading to a minimal sequence necessary for antagonistic activity.

Rijkers DT, Kruijtzer JA, van Oostenbrugge M, Ronken E, den Hartog JA, Liskamp RM. Rijkers DT, et al. Among authors: liskamp rm. Chembiochem. 2004 Mar 5;5(3):340-8. doi: 10.1002/cbic.200300769. Chembiochem. 2004. PMID: 14997526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters